Category: 4. Acute Coronary Syndromes: Therapy Background: High risk non-ST elevation acute coronary syndrome (HR-NSTE ACS) patients undergoing percutaneous coronary intervention (PCI), have a lower risk of bleeding with bivalirudin (BV) compared to unfractionated heparin (UFH) plus a GP IIb/IIIa inhibitor. We implemented a single center pilot protocol utilizing upstream BV in the emergency department(ED) for HR-NSTE ACS patients.
Methods:
A standardized chest pain protocol was implemented at Ridgeview Medical Center 30 miles away from the PCI center. In addition to aspirin and clopidogel, BV was recommended for HR-NSTE ACS (ST depression or positive troponin) prior to transfer for angiography and PCI if indicated. 
Results

Conclusions:
In contrast to success with STEMI and despite the potential benefit with upstream administration of BV vs. UFH, implementation of a protocol in the ED was challenging due to unfamiliarity and cost.
